Search

everythinglearnresearchcommunity

for

Search:↓

Cell-based therapies using dermal papilla cells and adipocyte lineage cells show potential for hair regeneration.

Finasteride reduces prostate bleeding by affecting blood vessel growth.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

A model called PM-DBiGRU was developed for analyzing sentiments in drug reviews, and it performed better than other models, but struggled with complex sentences and situations requiring background knowledge.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Effervescent formulations may improve minoxidil delivery, increasing effectiveness and reducing applications needed.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Excipients greatly affect how well curcumin nanocrystals penetrate the skin and target hair follicles.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Single Blimp1+ cells can create functional sebaceous gland organoids in the lab.

Caffeine applied to the scalp can protect hair follicles from UV damage.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Menopause affects hair and skin; more research needed for treatment.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Nanoencapsulation creates adjustable cell clusters for hair growth.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Finasteride doesn't affect hormone levels in normal men.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.